---

---

symbols : Jnj    crawled time : 14:30   

save search

---

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -1.53% | O: -0.13% H: 0.0% C: -2.94%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -1.85% | O: -1.65% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -3.74% | O: -1.06% H: 0.21% C: -1.05%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.33% | O: -3.02% H: 0.0% C: 0.0%
drug label astrazeneca expansion for kids

---

Major shareholder announcement – BlackRock, Inc.   
Published: 2024-04-10 (Crawled : 14:30) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -2.27% | O: 0.21% H: 0.0% C: 0.0%
BLK | $749.98 0.36% 0.0% 850K |

Finance

| -6.55% | O: -1.09% H: 0.17% C: -1.28%
announcement

---

Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials
Published: 2024-04-05 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -4.81% | O: -1.84% H: 0.0% C: 0.0%
neuroinflammatory back trials

---

Genmab, Kintara, Ginkgo and More Continue 2024 M&A Upswing
Published: 2024-04-03 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.23% | O: 0.02% H: 0.0% C: 0.0%

---

Endoscopy Equipment Market Worth $46.2 billion | MarketsandMarkets™
Published: 2024-03-28 (Crawled : 14:30) - prnewswire.com
SYK | $325.43 -0.62% 0.0% 1.8M |

Health Technology

| -9.28% | O: 0.14% H: 0.08% C: -0.37%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.25% | O: 1.32% H: 0.0% C: 0.0%
BSX | $67.33 -0.13% -0.31% 7M |

Health Technology

| -1.88% | O: 0.15% H: 0.28% C: -0.33%
MSFT | News F | $399.09 -1.28% -1.3% 29M |

Technology Services

| -5.29% | O: -0.11% H: 0.22% C: -0.06%
ISRG | $366.1 -1.75% -1.78% 3.8M |

Health Technology

| -8.44% | O: 0.34% H: 0.26% C: -0.59%
endoscopy market

---

Nuvation, Novo, AbbVie Boost Portfolios as Part of 2024 M&A Upswing
Published: 2024-03-26 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -4.95% | O: 0.01% H: 0.0% C: 0.0%
abbvie

---

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -2.47% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -4.9% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -4.21% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.44% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

---

Biopharma Layoff Tracker 2024: Catalent, NextCure, Bayer and More Cut Staff
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
RLYB | News | $1.75 4.79% 4.57% 310K |

| 7.32% | O: 2.44% H: 0.0% C: -4.76%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -4.9% | O: 0.02% H: 0.0% C: 0.0%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M |

Health Technology

| -38.21% | O: 1.63% H: 2.4% C: 0.8%
TXMD | News | $1.86 -1.59% -1.61% 10K |

Health Technology

| -19.13% | O: 2.61% H: 1.42% C: -2.97%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.44% | O: 1.47% H: 0.23% C: -0.19%
PTCT | News S | $25.32 2.55% 2.49% 3.9M |

Health Technology

| -16.08% | O: 0.1% H: 0.86% C: -3.68%
NKTR | News | $1.265 -4.17% -4.35% 4.7M |

Health Technology

| 38.19% | O: 0.3% H: 2.21% C: 1.5%
MOR | News | $17.96 -0.5% -0.5% 180K |

Health Technology

| -0.28% | O: 0.94% H: 0.11% C: -0.11%
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -12.99% | O: -0.69% H: 0.15% C: -1.3%
AMRN | News | $0.88 0.94% 0.93% 1M |

Health Technology

| -0.17% | O: 0.2% H: 4.26% C: -0.41%
GOOGL | News S | $154.08 -1.24% -1.25% 32M |

Technology Services

| 4.4% | O: 1.03% H: 1.65% C: 1.11%
GOOG | News S | $155.7 -1.12% -1.13% 20M |

Technology Services

| 4.69% | O: 1.01% H: 1.54% C: 1.02%
OCX | News J | $2.495 -2.54% -2.61% 50K |

Health Technology

| -18.03% | O: 0.0% H: 0.33% C: 0.33%
biopharma

---

Biopharma Layoff Tracker 2024: Bayer, Spruce, Takeda and More Cut Staff
Published: 2024-03-21 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -2.29% | O: 0.14% H: 0.24% C: 0.24%
RLYB | News | $1.75 4.79% 4.57% 310K |

| 4.76% | O: 1.19% H: 0.0% C: -3.53%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -4.93% | O: -0.03% H: 0.0% C: 0.0%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M |

Health Technology

| -38.71% | O: 0.0% H: 2.42% C: -0.81%
TXMD | News | $1.86 -1.59% -1.61% 10K |

Health Technology

| -20.85% | O: 0.43% H: 1.69% C: -2.54%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.16% | O: 0.3% H: 0.0% C: 0.0%
PTCT | News S | $25.32 2.55% 2.49% 3.9M |

Health Technology

| -14.2% | O: 1.56% H: 3.25% C: 0.67%
NKTR | News | $1.265 -4.17% -4.35% 4.7M |

Health Technology

| 37.78% | O: 1.44% H: 1.53% C: -1.72%
MOR | News | $17.96 -0.5% -0.5% 180K |

Health Technology

| -0.28% | O: 0.22% H: 0.17% C: -0.22%
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -14.37% | O: -0.97% H: 0.62% C: -0.62%
AMRN | News | $0.88 0.94% 0.93% 1M |

Health Technology

| -4.12% | O: -0.29% H: 2.85% C: -3.68%
GOOGL | News S | $154.08 -1.24% -1.25% 32M |

Technology Services

| 3.6% | O: 0.49% H: 0.6% C: -1.25%
GOOG | News S | $155.7 -1.12% -1.13% 20M |

Technology Services

| 4.04% | O: 0.43% H: 0.66% C: -1.05%
OCX | News J | $2.495 -2.54% -2.61% 50K |

Health Technology

| -18.57% | O: 0.0% H: 0.0% C: -0.65%
takeda biopharma

---

AZ-Fusion Deal, BMS $14B Karuna Purchase Highlight 2024 M&A Upswing
Published: 2024-03-19 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.65% | O: -0.1% H: 0.0% C: 0.0%

---

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Published: 2024-03-18 (Crawled : 14:30) - prnewswire.com
ZBH | $119.43 0.08% 0.0% 1.3M |

Health Technology

| -4.59% | O: 0.08% H: 0.82% C: 0.55%
SYK | $325.43 -0.62% 0.0% 1.8M |

Health Technology

| -7.61% | O: 0.51% H: 0.53% C: 0.02%
MDT | $79.48 0.37% -0.29% 6.7M |

Health Technology

| -4.89% | O: 0.28% H: 0.31% C: -0.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.53% | O: 0.2% H: 0.08% C: -1.14%
BDX | $234.12 0.42% 0.0% 1.3M |

Health Technology

| -1.09% | O: 0.38% H: 0.78% C: 0.05%
OMCL | $27.86 2.24% 2.19% 330K |

Technology Services

| 0.51% | O: 0.61% H: 0.47% C: -1.4%
ISRG | $366.1 -1.75% -1.78% 3.8M |

Health Technology

| -7.56% | O: 0.84% H: 0.42% C: -1.75%
EKSO | $1.35 11.57% 10.37% 52K |

Health Technology

| 0.0% | O: 1.52% H: 3.73% C: 0.0%
ARAY | $2.135 -3.39% -3.51% 630K |

Health Technology

| -18.01% | O: 0.38% H: 0.38% C: -1.91%
medical market

---

Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon
Published: 2024-03-18 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.53% | O: 0.2% H: 0.08% C: -1.14%
health

---

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -7.67% | O: 0.21% H: 0.97% C: 0.7%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -3.84% | O: 0.05% H: 0.14% C: -0.93%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.01% | O: -1.58% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -4.52% | O: -0.7% H: 0.73% C: -0.16%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -7.71% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.4% | O: -0.02% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| -6.49% | O: -0.27% H: 1.26% C: 0.84%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -0.96% | O: 0.2% H: 1.14% C: -1.18%
antibody therapeutics market

---

Novartis, Merck, J&J Add to 2024 M&A Upswing
Published: 2024-03-14 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.97% | O: -1.04% H: 0.0% C: 0.0%

---

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 1.82% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.94% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.18% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -3.66% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

---

Decision Tracker: FDA Decisions: Amgen’s Bone-Preserving Blockbuster Picks Up Two New Challengers
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.01% | O: 0.0% H: 0.8% C: 0.8%
PRGO | News | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 12.99% | O: -0.15% H: 3.43% C: 3.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -7.93% | O: -0.67% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -10.9% | O: -1.65% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.63% | O: -0.45% H: 0.0% C: 0.0%
fda

---

FDA Decisions: J&J’s Rybrevant Becomes First Front-Line Treatment for Type of NSCLC
Published: 2024-03-04 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.9% | O: -0.9% H: 0.0% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M |

Health Technology

| 16.98% | O: 0.65% H: 1.13% C: -1.02%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.6% | O: -0.42% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -9.45% | O: 0.03% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.28% | O: -0.8% H: 0.0% C: 0.0%
fda first treatment rybrevant

---

Immix Biopharma 12 Month Review Progress Update
Published: 2024-02-21 (Crawled : 14:30) - globenewswire.com
IMMX | $2.21 0.0% 64K |

| -26.76% | O: -1.34% H: 3.39% C: 1.36%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.67% | O: 0.8% H: 0.0% C: 0.0%
review update

---

Johnson &Johnson's nipocalimab granted U.S. FDA Breakthrough Therapy Designation for the treatment of individuals at high risk for severe hemolytic disease of the fetus and newborn (HDFN)
Published: 2024-02-09 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.81% | O: -0.68% H: 0.0% C: 0.0%
fda disease granted treatment risk designation therapy

---

FDA Sets Adcomm for BMS, J&J CAR T Therapies Amid Class-Wide Safety Concerns
Published: 2024-02-05 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.29% | O: -0.85% H: 0.0% C: 0.0%
fda

---

Gainers vs Losers

67%

33%

Top 10 Gainers

GBR | $1.42 31.48% 11.27% 990K |

Energy Minerals

KUKE | $2.88 2.49% 7.64% 360K |

MPLN | $0.6502 -11.74% 4.51% 2.2M |

Finance

CXM 4 | $11.34 -0.44% 4.27% 1.7M |

Information

PVL 4 | $1.47 -0.68% 4.08% 77K |

Energy Minerals

RNR 4 | $224.74 0.85% 3.52% 310K |

Finance

PZG | $0.4431 0.48% 2.91% 150K |

Non-Energy Minerals

DBRG | $17.3 0.06% 1.97% 1.2M |

Finance and Insurance

OSK 4 | $117.72 0.05% 1.96% 370K |

Producer Manufacturing

HYLN 4 | $1.29 -2.27% 1.55% 680K |

Producer Manufacturing

---

Your saved searches

---